Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia
Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma
A Phase I Extension Trial of Repeated Infusions of ISF35
A Phase I Trial of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35)
† Study has passed its completion date and status has not been verified in more than two years.